
Global & Australia Cancer Therapeutics Market to 2031
Description
According to the Australian Institute of Health and Welfare, approximately 160,000 new cancer cases were diagnosed across Australia in 2022, marking an increase from around 150,000 cases in 2021. Lung cancer continues to be the leading cause of cancer-related deaths, particularly affecting First Nations communities, where both smoking and cancer rates remain disproportionately high. Data from the Cancer Australia 2023 report revealed that 14,529 new cases of lung cancer were recorded in 2022—7,707 among males and 6,822 among females. This growing incidence underscores the urgent need for effective cancer treatments in the country.
To address this, the Australian government introduced a substantial initiative aimed at improving early detection and treatment outcomes. As outlined in a May 2023 Commonwealth of Australia report, the Minister for Health and Aged Care announced a US$263.8 million investment to roll out a National Lung Cancer Screening Program between 2023 and 2024, with full implementation targeted for July 2025. Developed in collaboration with the First Nations Health Sector, the program is designed to enhance lung cancer screening and prevention, with the potential to save over 500 lives each year. These strategic measures are expected to support the development and adoption of advanced cancer therapies, improving care for patients nationwide.
To address this, the Australian government introduced a substantial initiative aimed at improving early detection and treatment outcomes. As outlined in a May 2023 Commonwealth of Australia report, the Minister for Health and Aged Care announced a US$263.8 million investment to roll out a National Lung Cancer Screening Program between 2023 and 2024, with full implementation targeted for July 2025. Developed in collaboration with the First Nations Health Sector, the program is designed to enhance lung cancer screening and prevention, with the potential to save over 500 lives each year. These strategic measures are expected to support the development and adoption of advanced cancer therapies, improving care for patients nationwide.
Table of Contents
100 Pages
- 1. Introduction
- 1.1 Report Guidance
- 1.2 Market Segmentation
- 2. Executive Summary
- 2.1 Key Insights
- 3. Research Methodology
- 3.1 Secondary Research
- 3.2 Primary Research
- 3.2.1 Data Triangulation and Validation:
- 4. Australia Cancer Therapeutics Market Landscape
- 4.1 Overview
- 4.2 Ecosystem Analysis
- 4.2.1 List of Vendors in the Value Chain
- 5. Cancer Therapeutics Market Key Market Dynamics
- 5.1 Cancer Therapeutics Market – Key Market Dynamics
- 5.2 Market Drivers
- 5.3 Market Restraints
- 5.4 Market Opportunities
- 5.5 Future Trends
- 5.6 Impact of Drivers and Restraints
- 6. Australia Cancer Therapeutics Market – Analysis
- 6.1 Australia Cancer Therapeutics Market Revenue (US$ Million), 2021–2031
- 6.2 Australia Cancer Therapeutics Market Revenue and Forecast Analysis
- 7. Australia Cancer Therapeutics Market Analysis – by Therapy Types
- 7.1 Australia Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Therapy Types
- 8. Australia Cancer Therapeutics Market Analysis – by Indications
- 8.1 Australia Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Indications
- 9. Australia Cancer Therapeutics Market Analysis – by Distribution Channel
- 9.1 Australia Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Distribution Channel
- 10. Competitive Landscape
- 10.1 Heat Map Analysis by Key Players
- 10.1 Company Positioning and Concentration
- 11. Industry Landscape
- 11.1 Overview
- 11.2 Market Initiative
- 11.2 Partnerships and Collaborations
- 11.2 Other Developments
- 12. Company Profiles
- 12.1 Bristol-Myers Squibb Co
- 12.1. 1 Key Facts
- 12.1. 2 Business Description
- 12.1. 3 Products and Services
- 12.1. 4 Financial Overview
- 12.1. 5 SWOT Analysis
- 12.1. 6 Key Developments
- 12.2 AbbVie Inc
- 12.2. 1 Key Facts
- 12.2. 2 Business Description
- 12.2. 3 Products and Services
- 12.2. 4 Financial Overview
- 12.2. 5 SWOT Analysis
- 12.2. 6 Key Developments
- 12.3 Johnson & Johnson
- 12.3. 1 Key Facts
- 12.3. 2 Business Description
- 12.3. 3 Products and Services
- 12.3. 4 Financial Overview
- 12.3. 5 SWOT Analysis
- 12.3. 6 Key Developments
- 12.4 F. Hoffmann-La Roche Ltd
- 12.4. 1 Key Facts
- 12.4. 2 Business Description
- 12.4. 3 Products and Services
- 12.4. 4 Financial Overview
- 12.4. 5 SWOT Analysis
- 12.4. 6 Key Developments
- 12.5 Pfizer Inc
- 12.5. 1 Key Facts
- 12.5. 2 Business Description
- 12.5. 3 Products and Services
- 12.5. 4 Financial Overview
- 12.5. 5 SWOT Analysis
- 12.5. 6 Key Developments
- 12.6 AstraZeneca Plc
- 12.6. 1 Key Facts
- 12.6. 2 Business Description
- 12.6. 3 Products and Services
- 12.6. 4 Financial Overview
- 12.6. 5 SWOT Analysis
- 12.6. 6 Key Developments
- 12.7 Merck KGaA
- 12.7. 1 Key Facts
- 12.7. 2 Business Description
- 12.7. 3 Products and Services
- 12.7. 4 Financial Overview
- 12.7. 5 SWOT Analysis
- 12.7. 6 Key Developments
- 12.8 Novartis AG
- 12.8. 1 Key Facts
- 12.8. 2 Business Description
- 12.8. 3 Products and Services
- 12.8. 4 Financial Overview
- 12.8. 5 SWOT Analysis
- 12.8. 6 Key Developments
- 12.9 Astellas Pharma Inc
- 12.9. 1 Key Facts
- 12.9. 2 Business Description
- 12.9. 3 Products and Services
- 12.9. 4 Financial Overview
- 12.9. 5 SWOT Analysis
- 12.9. 6 Key Developments
- 12.10 Eli Lilly and Co
- 12.10. 1 Key Facts
- 12.10. 2 Business Description
- 12.10. 3 Products and Services
- 12.10. 4 Financial Overview
- 12.10. 5 SWOT Analysis
- 12.10. 6 Key Developments
- 13. Appendix
- 13.1 About Business Market Insights
- 13.2 List of Abbreviations
- TABLE OF TABLES
- Table 1. Australia Cancer Therapeutics Market Segmentation
- Table 2. List of Vendors
- Table 3. Australia Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million)
- Table 4. Australia Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million)
- Table 5. Australia Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Therapy Types
- Table 6. Australia Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy Types
- Table 7. Australia Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Indications
- Table 8. Australia Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
- Table 9. Australia Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel
- Table 10. Australia Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel
- Table 11. List of Abbreviations
- TABLE OF FIGURES
- Figure 1. Impact Analysis of Drivers and Restraints
- Figure 2. Australia Cancer Therapeutics Market Revenue, (US$ Million), 2021–2031
- Figure 3. Heat Map Analysis by Key Players
- Figure 4. Company Positioning and Concentration
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.